Philips Launches First Global Start-Up Collaboration Program Focused on the Application of Artificial Intelligence in Healthcare

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the launch of its first global start-up collaboration program involving Philips' innovation hubs in Cambridge (US), Eindhoven (the Netherlands), Bangalore (India) and Shanghai (China) focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology. After careful analysis, the most promising 19 early stage start-ups out of 750 applicants were selected for inclusion in Philips' proven incubator program for start-up companies.

Global, fast-track program

During the intensive 12-week 'AI in Healthcare for Radiology, Ultrasound and Oncology' program, Philips will simultaneously engage with the 19 early stage start-ups from 14 different countries, with the aim of validating their propositions, helping to build, test and scale their ideas, and exploring possible collaborations. In addition to benefitting from Philips' know-how and experience in the professional healthcare domain, the selected start-ups will have access to expertise in the company’s innovation ecosystem, which comprises hospital, academic, industry and financial partners.

"At Philips, we use intelligent technology to improve people's health across the health continuum - from healthy living and prevention to diagnosis, treatment and home care - while also increasing the efficiency of healthcare delivery," said Alberto Prado, Head of Philips Healthworks. "We are already working closely with clinical partners to develop AI-enabled solutions that are grounded in scientific research and validated in clinical practice. This new collaboration program recognizes the role that start-up companies play in bringing breakthrough healthcare innovations to the market."

Adaptive intelligence

AI-based solutions have great potential to improve patient outcomes and the efficiency of care delivery, but such solutions must be based on a thorough understanding of the clinical needs and developed in close collaboration with the care providers who will use them. Philips' vision is to use a combination of AI and other technologies with knowledge of the clinical and operational context in which they are used - a people-centered approach that it refers to as ‘adaptive intelligence'. The goal is to develop integrated solutions that adapt to the needs of healthcare providers and that are embedded into their workflows.

To support the adoption of AI in key healthcare domains, Philips has developed an AI platform for healthcare - Philips HealthSuite Insights - which delivers healthcare-specific tools and technologies to address the full process of building, maintaining, deploying and scaling AI solutions. The tools and technologies available through HealthSuite Insights already enable the machine learning and deep learning applications in Philips' diagnostic imaging solutions, telehealth solutions, and oncology and genomics offerings.

Philips' focus on innovation

Complementing the company’s global research and development program and its acquisitions driven portfolio extensions, Philips has extended its collaboration programs to health technology start-ups and venture capital activities. Philips HealthWorks accelerates breakthrough innovation through internal venturing and external start-up engagement. This program enables the company to assess, foster and monitor promising early stage start-up companies for potential future collaborations, as well as providing Philips with an in-depth view of the most recent developments in health technology from around the globe. In addition to HealthWorks, Philips has a separate team managing venture capital investing, Health Technology Ventures. HealthWorks and Health Technology Ventures collaborate to form a center of excellence for start-up companies looking to partner with Philips.

For further information, please visit:
https://www.healthworks.philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries.

Most Popular Now

A New Machine Learning Model can Classif…

Machine learning has improved dramatically in recent years and shown great promise in the field of medical image analysis. A team of research specialists at Dartmouth's Norris Cotton Cancer Center...

3D Child Welfare: How Data, Design and D…

Opinion Article by Rainer Binder, Managing Director, Global Employment and Social Services, Accenture Child welfare remains a pressing challenge for governments around the world, and the statistics are heart-breaking. In the...

Bringing more Human Intelligence to AI, …

The advent of data science, wireless connectivity and sensors, artificial intelligence (AI), and the Internet of Things (IoT) has raised the prospects for digital automation, smart hospital design and the...

HIMSS and Health 2.0 Take the Most Influ…

11 - 13 June 2019, Helsinki, Finland. The HIMSS & Health 2.0 European Conference will be held on 11 - 13 June 2019 in Helsinki, the capital of Finland. The conference...

DMEA 2019: International Exchange on Dig…

9 - 11 April 2019, Berlin, Germany. DMEA (formerly conhIT) is the industry's main event for digital healthcare. In that context, an international exchange of experiences and networking beyond national borders...

Scotland's Digital Health Leaders Recogn…

Scotland's digital health champions have been recognised for their achievements at the Holyrood Connect Digital Health and Care Awards 2019. William Edwards, director of eHealth at NHS Greater Glasgow and...

Philips to Expand its Radiology Informat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire the Healthcare Information Systems business of Carestream Health...

Three Winners of 2019 Sandoz Healthcare …

Sandoz, a Novartis division, announced the winners of the 2019 Sandoz Healthcare Access Challenge (HACk). Sandoz HACk invites entrepreneurs and innovators in the field of digital technology to submit ideas...

UK Sales of Xanax and other Prescription…

Sales of prescription psychiatric drugs such as Xanax and diazepam via darknet online drug markets have increased in the UK at an alarming rate, according to new research by the...

Study Finds Robots can Detect Breast Can…

Breast cancer is the most common cancer in women, and despite important improvements in therapy, it is still a major cause for cancer-related mortality, accounting for approximately 500,000 annual deaths...

Accenture Wins GLOMO Award for Virtual R…

The Accenture (NYSE: ACN) Virtual Experience Solutions (AVEnueS) has won "Best Mobile VR or AR" at the GSMA GLOMO Awards 2019. The award was presented at MWC19 Barcelona.